The ef­fect of opso­nins on ery­th­ro­cy­tes’ pha­go­cy­to­sis
in the vi­tre­ous – cli­ni­cal ob­se­rva­tions (part B)

Krystyna Raczyńska; Barbara Iwaszkiewicz-Bilikiewicz

Abstract

3/2004 vol. 106

Experimental research

The effect of opsonins on erythrocytes’ phagocytosis in the vitreous – clinical observations (part B)

Krystyna Raczyńska ¹

,

Barbara Iwaszkiewicz-Bilikiewicz ¹

Z Katedry i Kliniki Chorób Oczu Akademii Medycznej w Gdańsku

KLINIKA OCZNA 2004, Supl. 3: S404–S406

Online publish date: 2022/12/29

View full text

AMA

Raczyńska K, Iwaszkiewicz-Bilikiewicz B. The effect of opsonins on erythrocytes’ phagocytosis in the vitreous – clinical observations (part B). Klinika Oczna / Acta Ophthalmologica Polonica Supplement. 2004.

APA

Raczyńska, K., & Iwaszkiewicz-Bilikiewicz, B. (2004). The effect of opsonins on erythrocytes’ phagocytosis in the vitreous – clinical observations (part B). Klinika Oczna / Acta Ophthalmologica Polonica Supplement.

Chicago

Raczyńska, Krystyna, and Barbara Iwaszkiewicz-Bilikiewicz. 2004. "The effect of opsonins on erythrocytes’ phagocytosis in the vitreous – clinical observations (part B)". Klinika Oczna / Acta Ophthalmologica Polonica Supplement.

Harvard

Raczyńska, K., and Iwaszkiewicz-Bilikiewicz, B. (2004). The effect of opsonins on erythrocytes’ phagocytosis in the vitreous – clinical observations (part B). Klinika Oczna / Acta Ophthalmologica Polonica Supplement.

MLA

Raczyńska, Krystyna et al. "The effect of opsonins on erythrocytes’ phagocytosis in the vitreous – clinical observations (part B)." Klinika Oczna / Acta Ophthalmologica Polonica Supplement, 2004.

Vancouver

Raczyńska K, Iwaszkiewicz-Bilikiewicz B. The effect of opsonins on erythrocytes’ phagocytosis in the vitreous – clinical observations (part B). Klinika Oczna / Acta Ophthalmologica Polonica Supplement. 2004.

Purpose

We demonstrate clinical material collected during several years, which illustrates the possibilities of immunotherapy in intravitreous hemorrhages.

Material and methods

Immunotherapy was applied in 172 persons, Rh-positive in 174 eyes with intravitreal hemorrhages of a various etiology. The therapy consisted of injecting preparations containing IgG anti RhD antibodies into the vitreous.

Results

Visual acuity improvement has been obtained in 77,6% of eyes.

Conclusions

Summing up the effects of immunotherapy of hemorrhages into the vitreous body, it is necessary to stress the simplicity of performance of the procedure, its insignificant invasions and security resulting from the application of natural, human immunoglobulin.

Keywords

vitreous hemorrhage, IgG anti-RhD, immunotherapy